Taking into account possible challenges due to China's corruption crackdown
14/09/23 -"Despite Q1 exceeding expectations, thanks to healthy top-line growth and margin improvements, our target price resets c.10% lower due to potential headwinds related to the Chinese clampdown on ..."
Pages
64
Language
English
Published on
14/09/23
You may also be interested by these reports :
20/08/26
GN reported a weak quarter, impacted by challenging market conditions and subdued consumer sentiment. The decline in the top line was primarily ...
19/08/26
S&N Q2/H1 26 print disappointed: revenue missed consensus, forcing management to cut FY26 revenue growth guidance to 4% from 6%, while Orthopaedics ...
19/08/26
With the release of the 1H results, we have slightly adjusted our expectations. We account for no revenue from pre-approved services in 2026, and ...
18/08/26
Coloplast delivered a mixed Q3 FY26: revenue beat consensus (+1.2%) but EBIT missed (-1%), with the margin declining for a third straight quarter. ...